Connection

Mark George to Antidepressive Agents

Back to Details
This is a "connection" page, showing publications Mark George has written about Antidepressive Agents.
Mark George
Connection Strength
1.625
Antidepressive Agents
  1. Can Medication Free, Treatment-Resistant, Depressed Patients Who Initially Respond to TMS Be Maintained Off Medications? A Prospective, 12-Month Multisite Randomized Pilot Study. Brain Stimul. 2016 Mar-Apr; 9(2):251-7.
    View in: PubMed
    Score: 0.456
  2. A one-year comparison of vagus nerve stimulation with treatment as usual for treatment-resistant depression. Biol Psychiatry. 2005 Sep 01; 58(5):364-73.
    View in: PubMed
    Score: 0.225
  3. Shaping plasticity with non-invasive brain stimulation in the treatment of psychiatric disorders: Present and future. Handb Clin Neurol. 2022; 184:497-507.
    View in: PubMed
    Score: 0.174
  4. The assessment of resistance to antidepressant treatment: Rationale for the Antidepressant Treatment History Form: Short Form (ATHF-SF). J Psychiatr Res. 2019 06; 113:125-136.
    View in: PubMed
    Score: 0.144
  5. Is There Really Nothing New Under the Sun? Is Low-Dose Ketamine a Fast-Acting Antidepressant Simply Because It Is An Opioid? Am J Psychiatry. 2018 12 01; 175(12):1157-1158.
    View in: PubMed
    Score: 0.138
  6. Repetitive transcranial magnetic stimulation of the prefrontal cortex in depression. Exp Neurol. 2009 Sep; 219(1):2-13.
    View in: PubMed
    Score: 0.072
  7. Daily left prefrontal repetitive transcranial magnetic stimulation in the acute treatment of major depression: clinical predictors of outcome in a multisite, randomized controlled clinical trial. Neuropsychopharmacology. 2009 Jan; 34(2):522-34.
    View in: PubMed
    Score: 0.069
  8. Prefrontal EEG asymmetry as a potential biomarker of antidepressant treatment response with transcranial magnetic stimulation (TMS): a case series. Clin EEG Neurosci. 2008 Jul; 39(3):125-30.
    View in: PubMed
    Score: 0.068
  9. Acute left prefrontal transcranial magnetic stimulation in depressed patients is associated with immediately increased activity in prefrontal cortical as well as subcortical regions. Biol Psychiatry. 2004 May 01; 55(9):882-90.
    View in: PubMed
    Score: 0.051
  10. Can left prefrontal rTMS be used as a maintenance treatment for bipolar depression? Depress Anxiety. 2004; 20(2):98-100.
    View in: PubMed
    Score: 0.050
  11. The evidence is in: Repetitive transcranial magnetic stimulation is an effective, safe and well-tolerated treatment for patients with major depressive disorder. Aust N Z J Psychiatry. 2022 07; 56(7):745-751.
    View in: PubMed
    Score: 0.043
  12. Defining Treatment-Resistant Depression-Reply. JAMA Psychiatry. 2017 07 01; 74(7):759.
    View in: PubMed
    Score: 0.032
  13. Toward an Evidence-Based, Operational Definition of Treatment-Resistant Depression: When Enough Is Enough. JAMA Psychiatry. 2017 01 01; 74(1):9-10.
    View in: PubMed
    Score: 0.031
  14. The Clinical TMS Society Consensus Review and Treatment Recommendations for TMS Therapy for Major Depressive Disorder. Brain Stimul. 2016 May-Jun; 9(3):336-346.
    View in: PubMed
    Score: 0.029
  15. Durability of antidepressant response to vagus nerve stimulation (VNS). Int J Neuropsychopharmacol. 2007 Dec; 10(6):817-26.
    View in: PubMed
    Score: 0.016
  16. Vagus nerve stimulation for treatment-resistant depression: a randomized, controlled acute phase trial. Biol Psychiatry. 2005 Sep 01; 58(5):347-54.
    View in: PubMed
    Score: 0.014
  17. Effects of 12 months of vagus nerve stimulation in treatment-resistant depression: a naturalistic study. Biol Psychiatry. 2005 Sep 01; 58(5):355-63.
    View in: PubMed
    Score: 0.014
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.